Use of local anaesthesia for post operative pain management in cleft palate surgery

Comparative evaluation of Bupivacaine and Ropivacaine for post operative pain management in palatal surgeries- A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024906

Enrollment

Registered

2020-04-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q359- Cleft palate, unspecified

Interventions

Intervention1: Bupivacaine hydrochloride injection IP 0.5%: Bupivacaine hydrochloride injection IP 0.5% (ANAWIN) Control Intervention1: Ropivacaine hydrochloride injection IP 0.75%: Ropivacaine hydroc

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing the following surgery 1.primary palatoplasty 2.secondary palatoplasty 3.re-surgery for palatal fistula closure

Exclusion criteria

Exclusion criteria: Patients undergoing the following surgery 1. Secondary Alveolar Bone Grafting

Design outcomes

Secondary

Measure	Time frame
To identify any difference between post operative pain management with Bupivacaine hydrochloride injection and Ropivacaine hydrochloride injectionTimepoint: 1, 2, 4, 6, 8, 12, and 24 hours post operatively	—

Primary

Measure	Time frame
Post operative pain managementTimepoint: Post operative pain at 1, 2, 4, 6, 8, 12, and 24 hours	—

Countries

India

Contacts

Public ContactDr Madhulaxmi M

Saveetha Dental College

madhulaxmi11@gmail.com7373814000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026